tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ASLN Stock Latest News

Aslan Pharmaceuticals’ Eblasakimab Shows Promise
Company AnnouncementsAslan Pharmaceuticals’ Eblasakimab Shows Promise
2d ago
6K
ASLN
Aslan announces interim results from Phase 2 study of eblasakimab
PremiumThe Fly
Aslan announces interim results from Phase 2 study of eblasakimab
2d ago
ASLN
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
PremiumPress Releases
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
2d ago
ASLN
ASLAN Pharma Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
ASLAN Pharma Faces Nasdaq Compliance Challenge
5d ago
6K
ASLN
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
PremiumPress Releases
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
5d ago
ASLN
Aslan Pharmaceuticals receives Nasdaq notice
PremiumThe FlyAslan Pharmaceuticals receives Nasdaq notice
5d ago
ASLN
Aslan Pharmaceuticals Launches $12M ADS Offering
PremiumCompany Announcements
Aslan Pharmaceuticals Launches $12M ADS Offering
12d ago
6K
ASLN
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
12d ago
ASLN
Aslan Pharmaceuticals reports Q4 EPS (3c) vs (4c) last year
PremiumThe Fly
Aslan Pharmaceuticals reports Q4 EPS (3c) vs (4c) last year
12d ago
ASLN
ASLAN Pharmaceuticals Advances Clinical Trials
PremiumCompany Announcements
ASLAN Pharmaceuticals Advances Clinical Trials
12d ago
6K
ASLN
Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
PremiumPress Releases
Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
28d ago
ASLN
Aslan Pharmaceuticals files to sell 125M ordinary shares for holders
PremiumThe Fly
Aslan Pharmaceuticals files to sell 125M ordinary shares for holders
30d ago
ASLN
ASLN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsASLN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
ASLN
Aslan Pharmaceuticals price target lowered to $9 from $17 at H.C. Wainwright
PremiumThe Fly
Aslan Pharmaceuticals price target lowered to $9 from $17 at H.C. Wainwright
1M ago
ASLN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ACAD
ASLN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ACAD
APRE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
MRK
APRE
Aslan Pharmaceuticals price target lowered to $10 from $15 at Piper Sandler
PremiumThe Fly
Aslan Pharmaceuticals price target lowered to $10 from $15 at Piper Sandler
1M ago
ASLN
ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
PremiumPress Releases
ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
1M ago
ASLN
Aslan Pharmaceuticals announces $5M registered direct offering
PremiumThe FlyAslan Pharmaceuticals announces $5M registered direct offering
1M ago
ASLN
Piper ‘confident’ partner or buyer will see benefit of Aslan’s eblasakimab
PremiumThe Fly
Piper ‘confident’ partner or buyer will see benefit of Aslan’s eblasakimab
1M ago
ASLN
Aslan Pharmaceuticals provides TREK-DX study update
PremiumThe Fly
Aslan Pharmaceuticals provides TREK-DX study update
1M ago
ASLN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >